Form 4 Filing for Aquestive Therapeutics, Inc.

This filing details transactions made by Sherry Korczynski, Chief Commercial Officer of Aquestive Therapeutics, Inc. On September 9, 2026, Korczynski acquired 8,750 shares of Common Stock at a price of $2.65 per share, increasing her post-transaction holdings to 244,439 shares. Concurrently, she disposed of 8,750 shares of Common Stock at a price of $5.22 per share, resulting in post-transaction holdings of 235,689 shares. Additionally, Korczynski exercised a non-qualified stock option to buy 8,750 shares of Common Stock at an exercise price of $2.65 per share, with the options vesting in three annual installments. These transactions were executed under a Rule 10b5-1 Trading Plan. The filing indicates direct ownership of these securities.